Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | 2C22H28N2O5.2ClH.H2O |
| Molecular Weight | 891.873 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 12 / 12 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.Cl.Cl.[H][C@]12C[C@@H](O)[C@H](OC)[C@@H](C(O)=O)[C@@]1([H])C[C@@]3([H])N(CCC4=C3NC5=C4C=CC(OC)=C5)C2.[H][C@]67C[C@@H](O)[C@H](OC)[C@@H](C(O)=O)[C@@]6([H])C[C@@]8([H])N(CCC9=C8NC%10=C9C=CC(OC)=C%10)C7
InChI
InChIKey=LMWCWTONZRYETP-YATYINEESA-N
InChI=1S/2C22H28N2O5.2ClH.H2O/c2*1-28-12-3-4-13-14-5-6-24-10-11-7-18(25)21(29-2)19(22(26)27)15(11)9-17(24)20(14)23-16(13)8-12;;;/h2*3-4,8,11,15,17-19,21,23,25H,5-7,9-10H2,1-2H3,(H,26,27);2*1H;1H2/t2*11-,15+,17-,18-,19+,21+;;;/m11.../s1
Reserpic acid, a derivative of the antihypertensive drug reserpine, can inhibit norepinephrine uptake although it is much less effective than reserpine itself. Recently was shown, that reserpic acid possessed a strong binding to the pancreatic lipase, a major target for controlling the obesity.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P16233 Gene ID: 5406.0 Gene Symbol: PNLIP Target Organism: Homo sapiens (Human) |
|||
Target ID: P23975 Gene ID: 6530.0 Gene Symbol: SLC6A2 Target Organism: Homo sapiens (Human) |
4.5 µM [Ki] | ||
Target ID: P23975 Gene ID: 6530.0 Gene Symbol: SLC6A2 Target Organism: Homo sapiens (Human) |
4.5 µM [Ki] | ||
Target ID: P16233 Gene ID: 5406.0 Gene Symbol: PNLIP Target Organism: Homo sapiens (Human) |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sample Use Guides
Reserpic acid inhibits norepinephrine uptake although it is much less effective than reserpine itself. A Lineweaver-Burk analysis indicated that reserpic acid was a competitive inhibitor of norepinephrine transport. In the experiments: Ghosts were suspended in 1.0 ml of 0.4 M sucrose, 40 mM Mes, pH 6.8 or 1.0 ml of 0.4 M sucrose, 40 mM Hepes, pH 7.8, containing 5 mM ATP, 5 mM MgSO4, and concentration of inhibitor (reserpic acid): 3-300 uM. Chromaffin vesicles were prepared from the bovine adrenal medulla. Ghosts were prepared by resuspending the vesicles in the lysis medium.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID10409621
Created by
admin on Sat Dec 16 10:06:55 GMT 2023 , Edited by admin on Sat Dec 16 10:06:55 GMT 2023
|
PRIMARY | |||
|
m9533
Created by
admin on Sat Dec 16 10:06:55 GMT 2023 , Edited by admin on Sat Dec 16 10:06:55 GMT 2023
|
PRIMARY | Merck Index | ||
|
0GIZ7M31TN
Created by
admin on Sat Dec 16 10:06:55 GMT 2023 , Edited by admin on Sat Dec 16 10:06:55 GMT 2023
|
PRIMARY | |||
|
6105-91-5
Created by
admin on Sat Dec 16 10:06:55 GMT 2023 , Edited by admin on Sat Dec 16 10:06:55 GMT 2023
|
PRIMARY | |||
|
72710651
Created by
admin on Sat Dec 16 10:06:55 GMT 2023 , Edited by admin on Sat Dec 16 10:06:55 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD
